Abstract
Excessive fatty acid release from the white adipose tissue (WAT) contributes to the development of alcoholic liver disease (ALD). Lipin1 (LPIN1), as a co-regulator of DNA-bound transcription factors and a phosphatidic acid (PA) phosphatase (PAP) enzyme that dephosphorylates PA to form diacylglycerol (DAG), is dramatically reduced by alcohol in the WAT. This study aimed at determining the role of adipose LPIN1 in alcohol-induced lipodystrophy and the development of ALD. Transgenic mice overexpressing LPIN1 in adipose tissue (LPIN1-Tg) and wild type (WT) mice were fed a Lieber-DeCarli alcohol or isocaloric maltose dextrin control liquid diet for 8 weeks. Alcohol feeding to WT mice resulted in significant liver damage, which was significantly alleviated in the LPIN1-Tg mice. Alcohol feeding significantly reduced epididymal WAT (EWAT) mass, inhibited lipogenesis, and increased lipolysis in WT mice, which were attenuated in the LPIN1-Tg mice. LPIN1 overexpression also partially reversed alcohol-reduced plasma leptin levels. In WT mice, alcohol feeding induced hepatic lipid accumulation and down-regulation of beta-oxidation genes, which were dramatically alleviated in the LPIN1-Tg mice. LPIN1 overexpression also significantly attenuated alcohol-induced hepatic ER stress. These results suggest that overexpression of LPIN1 in adipose tissue restores WAT lipid storage function and secretive function to alleviate alcohol-induced liver injury.
Similar content being viewed by others
Introduction
Excessive alcohol consumption has been shown to disrupt lipid homeostasis in the liver and is associated with the development of liver diseases, including steatosis, steatohepatitis, fibrosis, and cirrhosis1,2,3. Excessive alcohol consumption also causes lipid dyshomeostasis at the adipose-liver axis, reducing lipid storage in white adipose tissue (WAT) and decreasing adipose mass, namely lipodystrophy4,5,6. As a major energy storage organ, WAT plays several key roles in mammalian physiology including storage excess energy in the form of triglycerides under positive energy balance conditions and releasing energy in the form of fatty acids under negative energy balance conditions. We and other groups have reported that adipose dysfunction impacts hepatic lipid metabolism6,7,8. WAT also controls energy homeostasis and metabolism through secretion of adipokines such as adiponectin and leptin9,10. Leptin is a hormone secreted by adipocytes that plays a pivotal role in the regulation of glucose and lipid metabolism11. It has been demonstrated that leptin stimulates triglyceride depletion in WAT and leptin levels are strongly correlated with both percentage fat mass and body mass index12.
The lipin protein family, consisting of three members, has been shown to have important roles in a variety of biological processes. The founding member of the family, Lipin1 (LPIN1), was identified in the fatty liver dystrophy mouse model in 200113. LPIN1, highly expressed in adipocytes, works as a phosphatidic acid (PA) phosphatase (PAP) enzyme that dephosphorylates PA to form diacylglycerol (DAG), which is the penultimate step in triglyceride (TG) synthesis14. It has been shown that LPIN1 accounts for all of the PAP activity in adipose tissue and skeletal muscle15. On the other hand, LPIN1 also works as a co-regulator of DNA-bound transcription factors to translocate to the nucleus and regulate metabolism14. It has been shown that LPIN1 directly interacts with peroxisome proliferator-activated receptor α (PPARα) and PPARγ coactivator 1α (PGC-1α) to modulate fatty acid oxidation gene expression16. LPIN1 also represses the activity of nuclear factor of activated T cells c4 (NFATc4) to inhibit cytokine production in adipocytes17. Our group has reported that LPIN1 was dramatically reduced by alcohol in WAT.
Although various functions of LPIN1 have been elucidated, the role of LPIN1 especially adipose LPIN1 in ethanol-induced lipolysis, hepatosteatosis, ER stress, inflammation, and hepatocyte apoptosis needs to be further explored. The present study was designed to determine the role of LPIN1 in the pathogenesis of alcohol-induced lipodystrophy and the development of ALD.
Results
Adipose-specific LPIN1 overexpression inhibits alcohol-induced lipolysis and promotes lipogenesis
EWAT masses of WT mice were significantly reduced by chronic alcohol feeding, adipose-specific LPIN1 overexpression significantly alleviated alcohol-induced reduction of EWAT masses (Fig. 1A). Alcohol feeding significantly decreased EWAT adipocyte size, from 32.44 ± 3.24 µm in WT-PF mice to 13.44 ± 2.99 µm in WT-AF mice. In contrast, adipose-specific LPIN1 overexpression significantly ameliorated alcohol-induced decrease of EWAT adipocyte size (from 35.39 ± 5.33 µm in LPIN1-Tg-PF mice to 20.11 ± 3.46 µm in LPIN1-Tg-AF mice) (Fig. 1B). Immunoblot results showed that in WT mice, alcohol feeding significantly reduced lipogenic genes or regulators, including PPARγ, ACC, FASN, LPIN1, and FATP1, but induced the expression of lipases including p-HSL and ATGL. Adipose-specific LPIN1 overexpression reversed alcohol-reduced expression of lipogenic genes or regulators and alcohol-induced expression of p-HSL and ATGL (Fig. 1C). Ex vivo study showed that adipose-specific LPIN1 overexpression significantly inhibited acetaldehyde-induced release of FFAs from EWAT (Fig. 1D).
Both phosphatidic acid phosphatase and co-regulator of DNA-bound transcription factors functions of LPIN1 contribute to its inhibition of lipolysis
RT-PCR results showed that human LPIN1β-GFP and catalytically dead human LPIN1β PAP mutant (LPIN1β-PAPm-GFP) were successfully overexpressed in 3T3-L1 cells (Fig. 2A). Transfected 3T3-L1 cells were challenged with acetaldehyde at a concentration of 100 µmol/L. Nile red staining showed that overexpression of LPIN1β-PAPm-GFP resulted in elevated lipid storage compared with that of adipocytes transfected with GFP, while overexpression of LPIN1β-GFP resulted in further elevation of lipid storage than that of adipocytes transfected with LPIN1β-PAPm-GFP. Administration of acetaldehyde resulted in adipocyte lipolysis, which was significantly alleviated by overexpression of either LPIN1β-PAPm-GFP or LPIN1β-GFP (Fig. 2B,C).
Adipose-specific LPIN1 overexpression alleviates alcohol-induced liver injury
Adipose-specific LPIN1 overexpression not only attenuated alcohol feeding-induced elevation of serum ALT and AST (Fig. 3A and B), but also normalized ethanol-increased ratios of liver weight to body weight (Fig. 3C). Hematoxylin and eosin (H&E) staining revealed that 8 weeks of alcohol feeding caused formation of lipid droplets (arrowheads) and necrosis (arrows) in the livers of WT mice, which were alleviated by adipose-specific LPIN1 overexpression (Fig. 3E). In addition, alcohol feeding also significantly elevated levels of both liver FFA and plasma FFA in WT mice, which were significantly alleviated by adipose-specific LPIN1 overexpression (Fig. 3D and F). Adipose-specific LPIN1 overexpression also diminished ethanol-elevated liver TG levels (Fig. 3G), whereas showed no significant effect on ethanol-decreased plasma TG levels (Fig. 3H). Ethanol-elevated liver cholesterol levels were significantly decreased by adipose-specific LPIN1 overexpression (Fig. 3I), but ethanol-decreased plasma cholesterol levels were not significantly affected by adipose-specific LPIN1 overexpression (Fig. 3J).
Adipose-specific LPIN1 overexpression restores alcohol-reduced fatty acid oxidation and attenuates alcohol-induced ER stress
Immunoblot results showed that in the livers of WT mice, alcohol feeding significantly reduced the expression of phosphor-PPARα, a transcription factor of lipid metabolism, and the expression of fatty acid oxidation related proteins, including CPT1α, ACOX1, and ACADL, which were reversed by adipose-specific LPIN1 overexpression. Although Adipose-specific LPIN1 overexpression showed no significant effect on the expression of RXRα and PGC-1α (Fig. 4A), it significantly reduced alcohol-induced ER stress markers, including p-eIF2α, ATF4, and CHOP (Fig. 4B).
Adipose-specific LPIN1 overexpression attenuates alcohol-reduced leptin level to alleviate alcohol-reduced fatty acid oxidation, attenuate alcohol-induced ER stress and protect against alcohol-induced hepatocyte apoptosis
Quantitative leptin assay showed that chronic alcohol feeding significantly inhibited the secretion of leptin in WT mice, which was partially reversed by adipose-specific LPIN1 overexpression (Fig. 5A). Adipose-specific LPIN1 overexpression showed no effect on adiponectin secretion (Fig. 5B). Western blots showed that treatment of AML12 cells with 100 µM acetaldehyde inhibited the expression of genes responsible for β-oxidation including p-PPARα, CPT1α, ACADL, and ACOX1 (Fig. 5C), and induced ER stress (Fig. 5D), which were reversed by treatment of cells with leptin (100 µM). TUNEL staining of hepatocytes showed that challenge of AML12 cells with 100 µM acetaldehyde resulted in significant apoptosis, which was dramatically alleviated by administration of leptin (Fig. 5E).
Adipose-specific LPIN1 overexpression attenuates alcohol-induced adipose tissue inflammation
RT-PCR results showed that pro-inflammatory cytokines and chemokines including TNFα, IL-6, and MCP1 were significantly induced by alcohol exposure in the EWAT of WT mice, which were significantly attenuated in the EWAT of LPIN1-Tg mice (Fig. 6A). Inflammatory infiltration markers including Ly6G and F4/80 were significantly upregulated by alcohol exposure in the EWAT of WT mice, which was attenuated by adipose-specific LPIN1 overexpression (Fig. 6B). Alcohol feeding or LPIN1 overexpression showed no effect on CD68 (Fig. 6B).
Discussion
The role of adipose-LPIN1 in alcohol-induced liver injury was investigated in this study. Data showed that adipose-specific LPIN1 overexpression protected mice against alcohol-induced liver injury via: (1) promoting alcohol-inhibited de novo lipogenesis but inhibiting alcohol-promoted lipolysis in white adipose tissue to restore alcohol-decreased size of adipocytes and the ratio of WAT to body weight, (2) promoting alcohol-inhibited β-oxidation in the liver to reduce ER stress, (3) increasing the release the leptin to alleviate alcohol-induced liver apoptosis, and (4) alleviating inflammation.
WAT is a major energy storage organ which stores energy in the form of triglycerides. The function and mass of WAT is tightly related to the synthesis and degradation of triglycerides. Excess free fatty acid flux or ectopic fat accumulation, has been considered as a key risk factor in the development of a number of chronic diseases, including type 2 diabetes and cardiovascular disease18. Excess adipose tissue lipolysis has also been shown to induce reverse-transportation of FFA from adipose tissue to liver and result in fatty liver6. Highly expressed in adipocytes, LPIN1 not only catalyzes the penultimate step in TG synthesis, i.e. from PA to DAG, but also works as a co-regulator of DNA-bound transcription factors to translocate to the nucleus and regulate metabolism14. This current study showed that in WAT of WT mice, alcohol feeding not only inhibited de novo lipogenesis but also promoted lipolysis, leading to lipid dyshomeostasis. In contrast, adipose-specific LPIN1 overexpression significantly alleviated alcohol-inhibited de novo lipogenesis and alcohol-induced lipolysis, thereby restored adipocyte size and the ratio of WAT to body weight and improved the energy storage function of WAT shown by reduced FFA release from WAT under acetaldehyde challenge (Fig. 1).
Our previous study has demonstrated that WAT expresses high levels of ALDH isoforms, including ALDH1A1, ALDH2 and ALDH3A1, but low level of ADH and CYP2E1, suggesting that WAT plays a role in aldehyde catabolism rather than ethanol catabolism. Indeed, we further showed acetaldehyde exposure, rather than ethanol exposure, suppressed lipogenetic enzymes including LPIN in 3T3-L1 cells8. In order to dissect the two functions of LPIN1, LPIN1β-GFP and catalytically dead LPIN1β PAP mutant (LPIN1β-PAPm-GFP) were successfully overexpressed in 3T3-L1 cells. The genetically modified 3T3-L1 cells were exposed to acetaldehyde to mimic alcohol exposure condition. Nile red staining results showed that overexpression of LPIN1β-PAPm-GFP resulted in elevated lipid storage, while overexpression of LPIN1β-GFP resulted in further elevation of lipid storage. Administration of acetaldehyde resulted in significant adipocyte lipolysis, which was alleviated by overexpression of either LPIN1β-PAPm-GFP or LPIN1β-GFP (Fig. 2). All the data suggested that both PAP and co-regulator of DNA-bound transcription factors functions contribute to enhanced lipid storage capacity. Previous study showed that LPIN1 functions as a key regulator of PPARγ activity through its ability to release co-repressors and recruit co-activators19. We observed that adipose specific LPIN1 overexpression reversed alcohol-suppressed PPARγ expression and other lipogenic gene expression including FASN and ACC, suggesting that LPIN1 might also regulate PPARγ expression directly through its co-regulator of DNA-bound transcription factors function.
Fatty acid β-oxidation is the catabolic process to broken down fatty acid molecules to generate acetyl-CoA in the mitochondria of eukaryotes. β-oxidation also occurs in peroxisomes when the fatty acid chains are too long to be handled by the mitochondria20. The enzyme catalyzing the first step of mitochondrial- and peroxisomal-β-oxidation is acyl-CoA dehydrogenases, which include very-long-chain, long-chain, medium-chain, and short-chain acyl-CoA dehydrogenases, and acyl-CoA oxidase (ACOX), respectively20,21. Alcohol feeding significantly inhibits ACADL and ACOX1, the enzymes responsible for both mitochondrial- and peroxisomal-β-oxidation. It has been shown that PPARα not only controls gene expression levels of the rate-limiting enzymes of peroxisomal β-oxidation, including ACOX1, but also directly controls ACADL expression levels to regulate the critical reaction of mitochondrial β-oxidation22,23,24. Our results showed that alcohol feeding significantly suppressed the expression of transcription factor phospho-PPARα and its targets genes including ACADL and ACOX1. Alcohol-suppressed fatty acid β-oxidation and abovementioned alcohol-enhanced adipose tissue lipolysis together led to hepatic ER stress shown by up-regulated phospho-eIF2α, ATF4 and CHOP. In contrast, adipose specific LPIN1 overexpression reversed alcohol-suppressed transcription factors and essential enzymes involved in fatty acid β-oxidation, improved the lipid storage function of WAT, and alleviated hepatic ER stress (Fig. 4). Previous studies showed that PGC1α was a coactivator of PPARα and RXR25,26,27, and PPARα binds as heterodimer with the retinoid X receptor (RXRα) to a specific DNA sequence termed the peroxisome proliferator response element (PPRE)28,29. However, in the present study, we did not see any effect of alcohol feeding on the expression of RXRα or PGC-1α either in WT mice or in LPIN1 transgenic mice.
Adipose tissue has recently recognized as endocrine tissue by producing multiple adipokines including leptin and adiponectin30,31,32,33,34. Decreased adiponectin levels are associated with dyslipidemia and levels of plasma adiponectin have been negatively correlated with triglycerides35,36,37. Abundantly expressed in adipose tissue, specifically adipocytes, leptin is involved in the regulation of energy homeostasis via inhibition of appetite and food intake and stimulation of energy expenditure31. This led us to determine the levels of leptin and adiponectin. As shown in Fig. 5, adipose specific LPIN1 overexpression significantly alleviated alcohol-reduced leptin level. Neither alcohol nor LPIN1 overexpression affected adiponectin level. Treatment of hepatocyte AML12 cells with the metabolite of alcohol, acetaldehyde, significantly inhibited transcription factors and enzymes involved in fatty acid β-oxidation, including phospho-PPARα, CPT1α, ACADL, and ACOX1 and resulted in hepatic ER stress shown by up-regulated phosphor-eIF2α, ATF4, and CHOP, which were abolished by administration of leptin. Moreover, administration of leptin significantly attenuated acetaldehyde-induced AML12 cell apoptosis. All the results suggested that leptin directly affects fatty acid β-oxidation and subsequent lipotoxicity and could be used for treatment of obesity and other diseases associated with hyperlipidemia (e.g. hypothyroidism, diabetes, renal insufficiency, etc.)38.
Inflammation has been involved in a variety of diseases including ALD and NAFLD39,40,41. Our group has showed that MCP1, IP-10, and KC play important roles in the animal model of ALD and alcohol feeding significantly induced inflammatory cell infiltration39. In this study, our data suggested that restoration of WAT lipid storage function and leptin secretion by overexpression of LPIN1 in adipose tissue significantly alleviated alcohol feeding-induced inflammatory cytokine production and inflammatory cell infiltration, which might shed light on the treatment of inflammatory diseases.
Conclusions
In short, the present study demonstrated that chronic alcohol feeding resulted in adipose tissue lipodystrophy and subsequent liver injury including ER stress, apoptosis, and inflammation. Overexpression of LPIN1 in adipose tissue protected mice against alcohol-induced liver injury through restoration of WAT lipid storage function and leptin secretion.
Materials and Methods
Generation of LPIN1 transgenic mice
All experiments were performed in accordance with relevant guidelines and regulations of North Carolina Research Campus. pBS aP2 promoter (5.4bk) polyA plasmid (#11424) and pLKO-puro FLAG wildtype, catalytic active LPIN1 plasmid (#32010) were obtained from Addgene (Cambridge, MA). The mouse LPIN1 coding sequence (without FLAG tag) was amplified with primers Lipin-F (5′-AGTTCTAGAGCGGCCACCATGAATTACGTGGGGCAGCTG-3′) and Lipin-R (5′-TCGTATTACGCGGCCGCTCAAGCTGAGGCTGA-3′). The amplified LPIN1 cDNA was cloned into the NotI site of the aP2 vector and sequence verified. The resulting AP2-LPIN1-SV40pA transgene was excised with KpnI and SacII and gel purified. The purified transgene was microinjected into C57BL/6J zygotes, which were implanted into surrogate females for transgenic founder production. Pups born from the microinjected embryos were genotyped with primers Lipin-SqF2 (5′- GCAGTTTGTGAACGAGGAGGATC-3′ and Lipin-SqR2 (5′- ATTGCCAACCTTGACCACGAG-3′) to get transgenic founders.
Animals and alcohol feeding
The animal protocol was approved by the Institutional Animal Care and Use Committee of the North Carolina Research Campus. Ten-week-old male wild type (WT) and LPIN1-Tg mice were pair-fed a modified Lieber-DeCarli alcohol or isocaloric maltose dextrin control liquid diet (Dyets, Bethlehem, PA) for 8 weeks (n = 8) with a stepwised feeding procedure, as described previously42. Briefly, the ethanol content (%, w/v) in the diet was started at 3.0 and gradually increased to 4.4. The amount of food given to the pair-fed mice was the same as what the alcohol-fed mice consumed in the previous day. At the end of 8-week feeding, mice were anesthetized with inhalation of isoflurane and tissues were collected.
Cell culture
Mouse AML12 hepatocytes (ATCC, Rockville, MD, USA) were cultured in Dulbecco’s modified eagle medium: Nutrient mixture F-12 (DMEM/F12, Thermo fisher scientific, Waltham, MA, USA) containing 10% fetal bovine serum (FBS; Atlanta Biologicals, Lawrenceville, GA), 100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen), at 37 °C in a humidified atmosphere of 5% CO2. 3T3-L1 fibroblast cells (ATCC, Rockville, MD, USA) were cultured and differentiated as previously described8,43.
Histopathological analysis
Plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity was colorimetrically measured using Infinity kits (Thermo Scientific, Waltham, MA). Liver tissue paraffin sections were prepared and stained with hematoxylin and eosin (H&E). Lipid quantitative assays were conducted by measuring the concentrations of hepatic triglyceride and FFA in the liver tissues using kits from BioVision (Milpitas, CA). Epididymal WAT (EWAT) paraffin sections were also prepared and stained with hematoxylin and eosin (H&E).
Quantitative assay of leptin
Levels of plasma leptin were measured with a commercial kit according to manufacturer’s instructions (Thermo Scientific, Waltham, MA).
Immunoblot analysis
Proteins from livers or cells were extracted using 10% Nonidet P-40 lysis buffer supplemented with protease inhibitor and phosphatase inhibitor (Sigma-Aldrich, St. Louis, MO). Aliquots containing 50 µg of proteins were loaded onto 8–12% SDS-PAGE, trans-blotted onto PVDF membrane, blocked with 5% nonfat milk in Tris-buffered saline solution with 0.1% Tween-20 for 1 hour at room temperature, and incubated with anti-LPIN1 (Abcam, Cambridge, MA), activating transcription factor 4 (ATF4), PGC1α (Novus Biologicals, Littleton, CO), phospo-peroxisome proliferator-activated receptor α (p-PPARα), PPARα (Thermo Scientific, Waltham, MA), fatty acid transport protein 1 (FATP1), C/EBP homologous protein (CHOP), β-actin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), fatty acid synthase (FASN), long chain acyl CoA dehydrogenase (ACADL), acyl CoA oxidase 1 (ACOX1), carnitine palmitoyltransferase 1A (CPT1α) (Proteintech, Rosemont, IL), acetyl-CoA carboxylase (ACC), phospho-hormone-sensitive lipase (p-HSL), adipose triglyceride lipase (ATGL), eukaryotic translation initiation factor 2α (eIF2α), phospho-eIF2α, RXRα, PPARγ (peroxisome proliferator-activated receptor-γ) antibody (Cell Signaling Technology, Danvers, MA), respectively. Membranes were washed and incubated with horseradish peroxidase–conjugated secondary antibodies (Thermo Scientific, Rockford, IL, USA). Bound complexes were detected via enhanced chemiluminescence (GE Healthcare, Piscataway, NJ, USA). Bands were quantified, and the ratio to β-actin was calculated and given as fold changes, setting the values of pair-fed or control at 1.
qPCR analysis
Total RNA was isolated from 3T3-L1 cells or EWAT with TRIzol reagent (Life Technologies, Grand Island, NY) and reverse transcribed with TaqMan Reverse Transcription Reagents (Applied Biosystems, Carlsbad, CA). The gene expression was measured in triplicate with SYBR green PCR Master Mix (Qiagen, Valencia, CA) by the comparative cycle threshold method using 7500 real time PCR system (Applied Biosystems). The primers (Table 1) were purchased from Integrated DNA Technologies (Coralville, IA). Data were normalized to 18s rRNA and expressed as relative changes setting the values of control as one.
Assessment of WAT lipolysis by ex vivo explants culture
Adipose tissue explants were obtained from the EWAT, cut into small pieces, and placed in a culture plate with pre-warmed PBS containing penicillin (100 U/ml) and streptomycin (100 mg/ml) to remove connective tissue and blood vessels. Explants (20 mg) were transferred to 24-well plates and cultured in 200 µl DMEM with L-glutamine (2 mM), penicillin (50 U/ml), streptomycin (50 mg/ml), and 2% fatty acid-free bovine serum albumin for 2 hours at 37 °C in the presence of absence of acetaldehyde (100 uM). FFA released in the culture medium was measured by a FFA Quantification Kit (BioVision, Mountain View, CA).
Effect of LPIN1 on lipid storage capability of 3TL-L1 cells
One day post-differentiation, 3T3-L1 cells were transfected with retroviral infectious media from the Phoenix cultures harboring human LPIN1β-GFP, catalytically dead human LPIN1β PAP mutant (LPIN1β-PAPm-GFP), or GFP (a general gift of Dr. Symeon Siniossoglou, Cambridge Institute for Medical Research, University of Cambridge) as previously described44,45,46. Two days post-transduction, cells were challenged with acetaldehyde (100 μM) for 3 days. Cells were either collected for mRNA measurement or fixed with 4% paraformaldehyde at room temperature for 30 min to process with nile red solution to stain neutral lipids. Fluorescent images were captured by Leica TCS SP5 confocal system (Leica, Wetzlar, Germany).
Assessment of the effect of leptin on ER stress and β-oxidation
Mouse AML12 hepatocytes (80% confluent) were challenged with acetaldehyde (100 µM, Sigma-Aldrich, St. Louis, MO) for 3 days in the presence or absence of leptin (100 ng/ml, BioVision, Milpitas, CA). Cells were collected and proteins were extracted.
Terminal deoxynucleotidyl transferase dUTP Nick End Labeling (TUNEL) assay
AML12 cells were routinely cultured in DMEM/F12 (Thermo Scientific, Waltham, MA). TUNEL assay kit (EMD Millipore, Billerica, MA) was used to detect DNA fragmentation47. Leptin (100 ng/ml, BioVision, Milpitas, CA), or acetaldehyde (100 µM, Sigma-Aldrich, St. Louis, MO) was used to treat AML12 cells for 3 days. Cell were fixed with 1% paraformaldehyde for 10 min, pretreated with proteinase K and H2O2, and incubated with the reaction mixture containing terminal deoxynucleotidyl transferase (TdT) and digoxigenin-conjugated dUTP for 1h at 37 °C. The labeled DNA was visualized with Alexa Fluor 594-conjugated anti-digoxigenin antibody (Jackson Immunoresearch, West Grove, PA). DAPI was used for counterstaining.
Statistical analysis
Data are expressed as mean ± standard deviation (SD). Results were analyzed using the one-sample t-test or one-way analysis of variance (ANOVA) followed by Turkey’s HSD. In all tests, P values less than 0.05 were considered statistically significant.
References
Beier, J. I., Arteel, G. E. & McClain, C. J. Advances in alcoholic liver disease. Current gastroenterology reports 13, 56–64, https://doi.org/10.1007/s11894-010-0157-5 (2011).
Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572–1585, https://doi.org/10.1053/j.gastro.2011.09.002 (2011).
Zhang, W., Zhong, W., Sun, Q., Sun, X. & Zhou, Z. Hepatic overproduction of 13-HODE due to ALOX15 upregulation contributes to alcohol-induced liver injury in mice. Scientific reports 7, 8976, https://doi.org/10.1038/s41598-017-02759-0 (2017).
Li, Q. et al. Preservation of hepatocyte nuclear factor-4alpha contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats. Alcoholism, clinical and experimental research 37, 587–598, https://doi.org/10.1111/acer.12013 (2013).
Sozio, M. S., Liangpunsakul, S. & Crabb, D. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Seminars in liver disease 30, 378–390, https://doi.org/10.1055/s-0030-1267538 (2010).
Zhong, W. et al. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. The American journal of pathology 180, 998–1007, https://doi.org/10.1016/j.ajpath.2011.11.017 (2012).
Wei, X. et al. Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: analysis of triacylglycerols using high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling. PloS one 8, e55382, https://doi.org/10.1371/journal.pone.0055382 (2013).
Zhang, W. et al. Visceral white adipose tissue is susceptible to alcohol-induced lipodystrophy in rats: role of acetaldehyde. Alcoholism, clinical and experimental research 39, 416–423, https://doi.org/10.1111/acer.12646 (2015).
Rosen, E. D. The transcriptional basis of adipocyte development. Prostaglandins, leukotrienes, and essential fatty acids 73, 31–34, https://doi.org/10.1016/j.plefa.2005.04.004 (2005).
Otto, T. C. & Lane, M. D. Adipose development: from stem cell to adipocyte. Critical reviews in biochemistry and molecular biology 40, 229–242, https://doi.org/10.1080/10409230591008189 (2005).
Minokoshi, Y., Toda, C. & Okamoto, S. Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle. Indian journal of endocrinology and metabolism 16, S562–568, https://doi.org/10.4103/2230-8210.105573 (2012).
Hynes, G. R. & Jones, P. J. Leptin and its role in lipid metabolism. Current opinion in lipidology 12, 321–327 (2001).
Peterfy, M., Phan, J., Xu, P. & Reue, K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nature genetics 27, 121–124, https://doi.org/10.1038/83685 (2001).
Mitra, M. S. et al. Mice with an adipocyte-specific lipin 1 separation-of-function allele reveal unexpected roles for phosphatidic acid in metabolic regulation. Proceedings of the National Academy of Sciences of the United States of America 110, 642–647, https://doi.org/10.1073/pnas.1213493110 (2013).
Reue, K. & Dwyer, J. R. Lipin proteins and metabolic homeostasis. Journal of lipid research 50(Suppl), S109–114, https://doi.org/10.1194/jlr.R800052-JLR200 (2009).
Finck, B. N. et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell metabolism 4, 199–210, https://doi.org/10.1016/j.cmet.2006.08.005 (2006).
Kim, H. B. et al. Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Molecular and cellular biology 30, 3126–3139, https://doi.org/10.1128/MCB.01671-09 (2010).
Britton, K. A. & Fox, C. S. Ectopic fat depots and cardiovascular disease. Circulation 124, e837–841, https://doi.org/10.1161/CIRCULATIONAHA.111.077602 (2011).
Kim, H. E. et al. Lipin1 regulates PPARgamma transcriptional activity. The Biochemical journal 453, 49–60, https://doi.org/10.1042/BJ20121598 (2013).
Poirier, Y., Antonenkov, V. D., Glumoff, T. & Hiltunen, J. K. Peroxisomal beta-oxidation–a metabolic pathway with multiple functions. Biochimica et biophysica acta 1763, 1413–1426, https://doi.org/10.1016/j.bbamcr.2006.08.034 (2006).
Kurtz, D. M. et al. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proceedings of the National Academy of Sciences of the United States of America 95, 15592–15597 (1998).
Rakhshandehroo, M., Hooiveld, G., Muller, M. & Kersten, S. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PloS one 4, e6796, https://doi.org/10.1371/journal.pone.0006796 (2009).
Gulick, T., Cresci, S., Caira, T., Moore, D. D. & Kelly, D. P. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proceedings of the National Academy of Sciences of the United States of America 91, 11012–11016 (1994).
Aoyama, T. et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). The Journal of biological chemistry 273, 5678–5684 (1998).
Vega, R. B., Huss, J. M. & Kelly, D. P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Molecular and cellular biology 20, 1868–1876 (2000).
Delerive, P., Wu, Y., Burris, T. P., Chin, W. W. & Suen, C. S. PGC-1 functions as a transcriptional coactivator for the retinoid X receptors. The Journal of biological chemistry 277, 3913–3917, https://doi.org/10.1074/jbc.M109409200 (2002).
Portilla, D. et al. Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure. Kidney international 62, 1208–1218, https://doi.org/10.1111/j.1523-1755.2002.kid553.x (2002).
Braissant, O., Foufelle, F., Scotto, C., Dauca, M. & Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354–366, https://doi.org/10.1210/endo.137.1.8536636 (1996).
Yang, T. et al. Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am J Physiol 277, F966–973 (1999).
Kershaw, E. E. & Flier, J. S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548–2556, https://doi.org/10.1210/jc.2004-0395 (2004).
Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature 395, 763–770, https://doi.org/10.1038/27376 (1998).
Berg, A. H., Combs, T. P., Du, X., Brownlee, M. & Scherer, P. E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature medicine 7, 947–953, https://doi.org/10.1038/90992 (2001).
Diez, J. J. & Iglesias, P. The role of the novel adipocyte-derived hormone adiponectin in human disease. European journal of endocrinology 148, 293–300 (2003).
Jung, U. J. & Choi, M. S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. International journal of molecular sciences 15, 6184–6223, https://doi.org/10.3390/ijms15046184 (2014).
Kanda, H. et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494–1505, https://doi.org/10.1172/JCI26498 (2006).
Matsubara, M., Maruoka, S. & Katayose, S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87, 2764–2769, https://doi.org/10.1210/jcem.87.6.8550 (2002).
Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y. & Libby, P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 110, 267–278, https://doi.org/10.1042/CS20050182 (2006).
Nelson, R. H. Hyperlipidemia as a risk factor for cardiovascular disease. Primary care 40, 195–211, https://doi.org/10.1016/j.pop.2012.11.003 (2013).
Zhang, W., Sun, Q., Zhong, W., Sun, X. & Zhou, Z. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice. Alcoholism, clinical and experimental research 40, 988–999, https://doi.org/10.1111/acer.13049 (2016).
Kwon, H. J. et al. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice. Hepatology 60, 146–157, https://doi.org/10.1002/hep.27036 (2014).
Zhong, W. et al. Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors. PloS one 8, e76522, https://doi.org/10.1371/journal.pone.0076522 (2013).
Zhang, W., Sun, Q., Zhong, W., Sun, X. & Zhou, Z. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice. Alcoholism, clinical and experimental research, https://doi.org/10.1111/acer.13049 (2016).
Zhang, W. et al. Adipocyte lipolysis-stimulated interleukin-6 production requires sphingosine kinase 1 activity. The Journal of biological chemistry 289, 32178–32185, https://doi.org/10.1074/jbc.M114.601096 (2014).
Zhang, W. et al. Sphingosine-1-phosphate receptor-2 mediated NFkappaB activation contributes to tumor necrosis factor-alpha induced VCAM-1 and ICAM-1 expression in endothelial cells. Prostaglandins & other lipid mediators 106, 62–71, https://doi.org/10.1016/j.prostaglandins.2013.06.001 (2013).
Sembongi, H. et al. Distinct roles of the phosphatidate phosphatases lipin 1 and 2 during adipogenesis and lipid droplet biogenesis in 3T3-L1 cells. The Journal of biological chemistry 288, 34502–34513, https://doi.org/10.1074/jbc.M113.488445 (2013).
Swift, S., Lorens, J., Achacoso, P. & Nolan, G. P. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Current protocols in immunology Chapter 10, Unit 10 17C, https://doi.org/10.1002/0471142735.im1017cs31 (2001).
Sun, Q., Zhang, W., Zhong, W., Sun, X. & Zhou, Z. Pharmacological inhibition of NOX4 ameliorates alcohol-induced liver injury in mice through improving oxidative stress and mitochondrial function. Biochimica et biophysica acta 1861, 2912–2921, https://doi.org/10.1016/j.bbagen.2016.09.009 (2016).
Acknowledgements
This research was supported by the National Institutes of Health grants (R01AA018844, R01AA020212).
Author information
Authors and Affiliations
Contributions
W.Z.: study design, acquisition of data, analysis and interpretation of data, drafting of the manuscript. W.Z.: animal study, acquisition of data, critical revision of the manuscript. Q.S.: animal study, acquisition of data, critical revision of the manuscript. X.S.: animal study, acquisition of data. Z.Z.: study concept and design, drafting and critical revision of the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, W., Zhong, W., Sun, Q. et al. Adipose-specific lipin1 overexpression in mice protects against alcohol-induced liver injury. Sci Rep 8, 408 (2018). https://doi.org/10.1038/s41598-017-18837-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-18837-2
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.